BCL2 and neoplasm: Akt activation inhibits apoptosis by phosphorylating pro-apoptotic proteins (e.g., BAD and BAX) and upregulating anti-apoptotic genes (e.g., Bcl-2), thereby protecting tumor cells from PCD [68].